MS patients presented an increased connectivity when treated with IFN-β (maximum Kolmogorov–Smirnov test p-values p=10-48 GSE41846, p=10-15 GSE16214; Figure 3a,c) in the two more numerous datasets. Here, IFNB1 is linked to myeloid sarcoma.